PharVision Advisers »

Clii shares owned by PharVision Advisers

Quarter-by-quarter ownership of Clii (EVGO) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Clii

Tip: Access up to 7 years of quarterly data

All positions including Clii held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Clii by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $95k 20k 4.73

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Clii

Vanguard Group
BlackRock
Millennium Management
J. Goldman & Co
SIR Capital Management
Soros Fund Management
State Street Corporation
Geode Capital Management
Goldman Sachs Group
HITE Hedge Asset Management
Morgan Stanley
Invesco
Qube Research & Technologies
Bnp Paribas Arbitrage, Snc
Tudor Investment Corporation

View all funds holding Clii